Development of self-adjuvanting polymer-peptide conjugates as therapeutic vaccine against cervical cancer

• In: SUBMITTED ORALS on Tuesday, 15 April 2014, 13:00-14:30
• At: PSWC, Melbourne (Australia) (2014)
• Type: Presentation
• By: LIU, Tzu-Yu (University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, Australia)
• Co-author(s): Hussein (University of Queensland, Brisbane, Australia)
  Jia (University of Queensland, Brisbane, Australia)
  Mcmillan (Griffith University, Gold coast, Australia)
  Monteiro (University of Queensland, Brisbane, Australia)
  Toth, Istvan (University of Queensland, Brisbane, Australia)
  Skwarczynski (University of Queensland, Brisbane, Australia)
  
• Abstract:

  Background
  Cervical cancer is the second most common cancer in women worldwide and this cancer is caused by high-risk types of human papillomavirus (HPV), most commonly HPV-16. Prophylactic HPV vaccines were commercialized and are clinical effective in preventing HPV infection but do not have a therapeutic effect against established HPV infection. ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login